Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Findings could aid efforts to harness nature for making drugs

29.01.2004


Chemical engineers at Purdue University have shown how to make yeast cells double the activity and boost productivity of a type of enzyme plants need to create important chemicals such as anticancer compounds.

The work is related to efforts aimed at developing techniques to use plants and microorganisms as natural factories for producing pharmaceuticals. Such techniques would be safer and more environmentally friendly than conventional methods for making drugs, which often require hazardous chemicals and steel "reactors" operated at high pressures and temperatures. The enzymes from plants and other organisms typically function in water near room temperature under ordinary pressure.

The Purdue researchers demonstrated that altering the nutrients and carefully controlling fermentation time caused yeast cultures to produce an enzyme called ferulate 5-hydroxylase that has twice its normal rate of activity, which increases the enzyme’s productivity.



"Activity relates to the amount of product that can be synthesized in a given time," said John Morgan, an assistant professor of chemical engineering at Purdue. "So we could make more than twice the amount of product per hour."

Findings are detailed in a paper appearing in the Jan. 20 issue of the journal Biotechnology and Bioengineering, published by John Wiley & Sons Inc. The paper was written by Morgan and Purdue doctoral student Hanxiao Jiang.

The enzyme is a member of a family of enzymes called cytochrome P450, which plants need to produce numerous chemical compounds.

Plants ordinarily produce small quantities of "flavonoids," which are beneficial chemicals known as antioxidants. So researchers are developing ways to boost production of the chemicals by transferring vital enzymes from plants to microorganisms. Because P450 enzymes are "biocatalysts" that enable an organism to produce the beneficial drugs, researchers are trying to develop techniques that cause plants to make greater quantities of the enzymes and enzymes that are more productive.

The method pursued by the Purdue researchers was to focus on a gene responsible for producing ferulate 5-hydroxylase.

Altering the composition of nutrients fed to the yeast cultures and controlling the fermentation time caused the gene to be "expressed," producing 45 percent more of the enzyme while doubling the enzyme’s activity.

Increasing the quantity and activity of various cytochrome P450 enzymes might enable scientists to use plants and microorganisms like E. coli and baker’s yeast to one day commercially produce pharmaceuticals. More progress is needed, however, before it will be practical to use plants and plant enzymes in microorganisms as natural pharmaceutical factories, Morgan said.

"I wouldn’t consider this a major breakthrough, but it does represent significant progress in improving the expression of the enzyme," he said. "I think there is certainly room for greater expression of these P450 enzymes."

The same technique could be used to increase the production of other P450 enzymes, Morgan said.

"The plant kingdom contains a large and relatively untapped diversity of P450s that are needed to create thousands of valuable natural products," he said.

In ongoing work, the Purdue researchers also are trying to develop methods for coaxing the enzymes to make drugs not normally produced by plants.

"We are feeding them what’s known as substrate analogs, or compounds that are structurally similar to the compound that this enzyme will normally recognize and react with but are somewhat structurally different," Morgan said. "Therefore, if the enzyme recognizes this compound, it will produce a novel product, or a product that’s never been synthesized before.

"From a scientific standpoint, we want to better understand precisely how organisms make certain compounds, and from an engineering standpoint, we want to devise a strategy for manipulating the organism so that it makes the chemicals we want it to make."

Writer: Emil Venere, (765) 494-4709, venere@purdue.edu
Source: John Morgan, (765) 494-4088, jamorgan@ecn.purdue.edu
Purdue News Service: (765) 494-2096; purduenews@purdue.edu

Note to Journalists: An electronic copy of the research paper is available from Emil Venere, (765) 494-4709, venere@purdue.edu

Emil Venere | Purdue News
Further information:
http://news.uns.purdue.edu/html4ever/2004/040128.Morgan.enzyme.html

More articles from Life Sciences:

nachricht A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich

nachricht New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>